Natural variability and the influence of concurrent control values on the detection and interpretation of low-dose or weak endocrine toxicities.
about
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responsesComparison of study controlsEstrogenic activity of cosmetic components in reporter cell lines: parabens, UV screens, and musksActivity of xenoestrogens at nanomolar concentrations in the E-Screen assayKey learnings from the Endocrine Disruptor Screening Program (EDSP) Tier 1 rodent uterotrophic and Hershberger assays.Screening and testing for endocrine disruption in fish-biomarkers as "signposts," not "traffic lights," in risk assessment.Statistical power considerations show the endocrine disruptor low-dose issue in a new lightAn updated weight of the evidence evaluation of reproductive and developmental effects of low doses of bisphenol A.The polybrominated diphenyl ether mixture DE-71 is mildly estrogenicThe "low dose" hypothesis: validity and implications for human risk.Reproductive toxicants have a threshold of adversity.Arrhythmogenic effect of androgens on the rat heart.Camphor Induces Proliferative and Anti-senescence Activities in Human Primary Dermal Fibroblasts and Inhibits UV-Induced Wrinkle Formation in Mouse Skin.Does the prenatal bisphenol A exposure alter DNA methylation levels in the mouse hippocampus?: An analysis using a high-sensitivity methylome technique.Connexin 43 expression in the testes during postnatal development of finasteride-treated male rat offspring
P2860
Q24613799-388F0F45-7F5D-4F35-B1AA-889555AC2F07Q24815765-E0EEDEFB-0079-43ED-84E1-404F5F16F6A4Q28242495-65B417BF-91DF-4CD1-888C-86D9358E9E80Q34733079-FB56F7E5-C919-4FB7-97C4-057ED39C2D15Q35023310-8BBBABDD-5248-4152-ABB6-58001C42D797Q35803411-70420CB0-CB8B-4DAD-AEC4-5C1E735EFCB0Q36326673-094E9872-ACED-4685-89AE-D64A504526AEQ36586067-DB00A318-F595-49DC-8596-0B5FBD34E925Q36633056-6035211D-396F-40E4-A8D3-0A0D6D3B568EQ36761782-DB2446EF-069D-494C-BEFF-2D2D704BEFDCQ37879187-C2624E32-1D77-40FC-BF38-EAE8D840118FQ46540307-A469ABA4-0129-4930-9C9D-AD5F41D92F25Q46656060-0A11A66F-2EB2-4C47-BCA9-7A3F2FE341CFQ55395474-E3901826-C54F-45F6-80CA-00BEC1265562Q58588409-CA5E939F-31AF-4B45-A617-4C7366493397
P2860
Natural variability and the influence of concurrent control values on the detection and interpretation of low-dose or weak endocrine toxicities.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Natural variability and the in ...... e or weak endocrine toxicities
@nl
Natural variability and the in ...... or weak endocrine toxicities.
@ast
Natural variability and the in ...... or weak endocrine toxicities.
@en
type
label
Natural variability and the in ...... e or weak endocrine toxicities
@nl
Natural variability and the in ...... or weak endocrine toxicities.
@ast
Natural variability and the in ...... or weak endocrine toxicities.
@en
prefLabel
Natural variability and the in ...... e or weak endocrine toxicities
@nl
Natural variability and the in ...... or weak endocrine toxicities.
@ast
Natural variability and the in ...... or weak endocrine toxicities.
@en
P2093
P2860
P356
P1476
Natural variability and the in ...... or weak endocrine toxicities.
@en
P2093
Helen Tinwell
Jenny Odum
John Ashby
Paul Lefevre
P2860
P304
P356
10.1289/EHP.6862
P407
P577
2004-06-01T00:00:00Z